Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
Study sponsor: Eledon Pharmaceuticals
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2029-12Estimated
Enrollment · participants132Estimated
Source updated2025-12-10Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.